Innate Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Innate Pharma and buy or sell other stocks, ETFs, and their options commission-free!About IPHA
Innate Pharma SA is a global, clinical-stage biotechnology company, which engages in developing immunotherapies for cancer patients. Its product pipeline includes Lacutamab, Monalizumab, Avdoralimab, and IPH62.
CEOJonathan Dickinson
CEOJonathan Dickinson
Employees163
Employees163
HeadquartersMarseille, Provence-Alpes-Cote-dAzur
HeadquartersMarseille, Provence-Alpes-Cote-dAzur
Founded1999
Founded1999
Employees163
Employees163
IPHA Key Statistics
Market cap172.16M
Market cap172.16M
Price-Earnings ratio-2.90
Price-Earnings ratio-2.90
Dividend yield—
Dividend yield—
Average volume4.96K
Average volume4.96K
High today$1.81
High today$1.81
Low today$1.79
Low today$1.79
Open price$1.81
Open price$1.81
Volume2.44K
Volume2.44K
52 Week high$2.63
52 Week high$2.63
52 Week low$1.17
52 Week low$1.17
IPHA News
TipRanks 4d
Innate Pharma Completes Phase 1 Dose Escalation Enrollment for Nectin-4 ADC IPH4502 - TipRanks...
TipRanks 4d
Innate Pharma completes enrollment in dose escalation of IPH4502 studyInnate Pharma (IPHA) announced the completion of enrollment in the dose escalation of the Phase 1 study of IPH4502, its proprietary Nectin-4 exatecan ADC. Preli...
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.